In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hexal AG

Division of Novartis AG
www.hexal.de

Latest From Hexal AG

Generics Players Dominating New OTC Launches In Germany

An analysis by Sempora Consulting of the German OTC market in 2018 shows that generic products dominate new OTC product launches.
Health OTC Drugs

German Industry Wants To Simplify 'Complicated' Switch Process

The German Medicines Manufacturers´ Association, the BAH, is calling for the country's prescription-to-OTC reclassification procedure to be simplified by removing from the process the country's Ministry of Health and Bundesrat, and empowering the medicines agency, BfArM, to make the final decision based on recommendations from the Expert Advisory Committee for Prescription. 
Health OTC Drugs

Life’s An Itch And Then You Cry – New Hay Fever Products And Campaigns In Germany This Spring

New OTC products and campaigns for the hay fever season from: GSK, Novartis, Dermapharm, Galenpharma, DHU and Thea Pharma.
Health OTC Drugs

Hexal Sues EMA Over Refusal To Accept Generic Aubagio Filing

Hexal is challenging a decision by the European Medicines Agency to reject its application for a generic version of Sanofi’s MS drug Aubagio, raising fresh questions about how a new active substance is defined. By contrast, a generic version from Glenmark was recently approved in the US.

Generic Drugs Europe
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register